2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Date

Saturday, May 30, 2020

3:30pm-4:00pm: Epithelial To Mesenchymal Transition Mediates Engraftment Of Endoderm And Hepatic Progenitor Cells In The Quiescent Liver

W. S. Fagg¹, N. Lui², L. Patrikeev³, O. Saldarriaga*⁴, H. Lerner-Stevenson⁵, V. Popov⁶, M. Motamade³, J. H. Fair¹

Poster Session D: Cellular Therapies, Tissue Engineering / Regenerative Medicine • Virtual

3:30pm-4:00pm: Epitope Analysis of Complement-Binding De Novo Donor-Specific HLA Class II Antibody

K. Yamanaka, M. Hashimoto, T. Kinoshita, Y. Fujita, S. Matsumura, T. Imanaka, A. Taniguchi, T. Yoshida, H. Kishikawa

Poster Session A: Kidney Acute Antibody Mediated Rejection • Virtual

3:30pm-4:00pm: Eplet Mismatch Imputed from HLA Serotype-Level Data Can Improve Risk Stratification for Kidney Allograft Loss

A. Heinzel, R. Reindl-Schwaighofer, A. Kainz, K. Hu, R. Oberbauer

Poster Session A: Histocompatibility and Immunogenetics • Virtual

3:30pm-4:00pm: Eplet Mismatch Not Correlated with Antibody Mediated Rejection or Allograft Loss Among Kidney Transplant Recipients with De Novo Donor Specific Antibody

A. Basu¹, W. Jiqiu², A. Bentall², M. Gandhi², B. Dukek², N. Henderson², C. Schinstock²

Poster Session A: Kidney Acute Antibody Mediated Rejection • Virtual

3:30pm-4:00pm: Epstein-Barr Virus (EBV)+ Post-Transplant Lymphoproliferative Disorder (PTLD) is Associated with Tumor CCL3/CCL4 Expression and an Increase in Tumor-Infiltrating Monocytes

J. Toh¹, F. Vallania¹, W. A. Haynes¹, G. Bhagat², F. E. Craig³, S. H. Swerdlow⁴, T. Tousseyn⁵, S. M. Krams¹, P. Khatri¹, O. M. Martinez¹

Poster Session C: PTLD/Malignancies: All Topics • Virtual

3:30pm-4:00pm: Epstein-Barr Virus-Specific Cytotoxic T Lymphocyte Precursors (EBV-CTLp) after Tab-cel Correlates with Response & Survival in Rituximab Relapsing or Refractory Ebv⁺ Posttransplant Lymphoproliferative Disease (PTLD)

R. Shen¹, N. Guzman-Becerra¹, Y. Sun¹, F. Forozan¹, S. Prockop², E. Doubrovina², R. O'Reilly², X. Li¹, M. Hiremath³, L. Gamelin¹, W. Navarro¹, B. Aftab¹

Poster Session D: PTLD/Malignancies: All Topics • Virtual

3:30pm-4:00pm: Erythropoietin Reduces Alloantibody Formation by Inhibiting T Follicular Helper Cells

C. Cantarelli¹, C. Guglielmo², S. Bin², A. Cumpelik², C. Donadei³, L. Anderson⁴, S. Hartzell², K. Budge², M. Haverly², A. Angeletti³, G. La Manna³, E. Fiaccadori¹, U. Maggiore¹, P. Heeger², P. Cravedi²

Poster Session D: B-cell / Antibody /Autoimmunity • Virtual

3:30pm-4:00pm: ESAT-6, A Novel Protein Originally Produced by M. Tuberculosis, Inhibits Central Memory CD8+ T Cell Generation and Allograft Rejection

F. Qiu, S. Ye, H. Liu, Z. Dai

Poster Session C: Immunosuppression Preclinical Studies • Virtual

3:30pm-4:00pm: ESRD Risk Prediction for Black vs. White Related Living Kidney Donors

J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, L. Cartwright¹, D. Stewart¹

Poster Session C: Kidney Living Donor: Long Term Outcomes • Virtual

3:30pm-4:00pm: Establishing an Induction Protocol for Long-Term Multilineage Mixed Chimerism in Rhesus Macaques

K. Bruestle¹, H. Sakai¹, F. Fredriksson¹, B. Piegari¹, D. Ekanayake-Alper¹, A. McLuckie², R. Ober², J. Weiner¹, A. Iuga³, S. M. Coley³, M. Sykes¹, A. Griesemer¹

Poster Session A: Tolerance / Immune Deviation • Virtual